cecava GmbH is a biopharmaceutical immuno-oncology company located in Tuebingen (Germany). Founded in 2018, cecava’s mission is to develop individualized peptide cancer therapies (INPECT). The therapy is tailored to target the patient-individual tumor mutations. Through immunizations with the AI-selected neoepitope peptides, the immune system is activated and directed against the patient’s tumor. Based on encouraging real-world experience with this novel immunotherapy, clinical trials are currently being prepared. The company’s ultimate goal is to secure the approval for this innovative treatment, ensuring that as many cancer patients as possible may benefit.
Company Details
- Employees
- 6
- Founded
- 2018
- Address
- Paul-Ehrlich Straße, Tübingen,baden-Württemberg 72076,germany
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Tübingen, Baden-Württemberg
Cecava Gmbh Questions
Cecava Gmbh's LinkedIn profile is https://de.linkedin.com/company/cecava-gmbh
Cecava Gmbh has
6 employees.
View email and phone details for 6
employees at Cecava Gmbh.
Cecava Gmbh's industry is
Biotechnology Research
Cecava Gmbh's top competitors are
Pfizer,
Glioblastoma Research Organization,
Cegat Gmbh,
Centogene,
Daiichi Sankyo Europe Gmbh,
Blue River Canyoning,
Curevac,
Sophia Genetics,
Grit Bio, Inc.,
Illumina.
Cecava Gmbh's categories are Biotechnology Research
Cecava Gmbh's founding year is 2018
